MEDIAN Technologies boosts its presence in the US and announces major expansion of its subsidiary MEDIAN Technologies Inc.

Sophia Antipolis, France
  • Opening of a new facility in Woburn, near Boston, Massachusetts
  • Increased operational capacity for MEDIAN Technologies Inc.
  • Ambitious recruitment plan for the US

MEDIAN Technologies (ALMDT.PA), a leading medical imaging solutions and service provider for image interpretation and management in oncology, today announced its US expansion plans with the opening of a major facility for its US subsidiary MEDIAN Technologies Inc. The new site in Woburn, Massachusetts will bring together all of the teams located around the Boston area and has the capacity to handle the ambitious US recruitment plan over the coming months. With this new space and expected employee growth, MEDIAN Technologies Inc. demonstrates a major increase in its operational capacity for the management of imaging projects in clinical trials.

“By strengthening our presence in the US through MEDIAN Technologies Inc., we will be able to provide the best possible service to our US customer base. In 2015, 43.5% of our revenue was produced in North America. A more permanent, stronger establishment in the US market was an essential step for us. We had also made this commitment to our investors and customers. It’s now a done deal,” said Fredrik Brag, CEO of MEDIAN Technologies “The Boston area is an extraordinary breeding ground for all the biopharmaceutical industry players, particularly in the field of oncology. Large pharmaceutical companies and biotechnology companies, which are either already our customers or potential customers, are very present in the region. This will provide us with great momentum and help fuel our on-going growth.”

The facility, Trade Center 128, located at 300 Trade Center, Suite 5610, 01801 Woburn, MA, USA will be operational as of May 16, 2016.

Download US_Expansion_20160512.pdf